newsfilter
← Latest News
GlobeNewswire·

CervoMed to Participate in the Canaccord Genuity 45th Annual Growth Conference

BOSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ:CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced that Company management will